BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30221742)

  • 1. Novel SIRT1 inhibitor 15-deoxy-Δ12,14-prostaglandin J2 and its derivatives exhibit anticancer activity through apoptotic or autophagic cell death pathways in SKOV3 cells.
    Tae IH; Park EY; Dey P; Son JY; Lee SY; Jung JH; Saloni S; Kim MH; Kim HS
    Int J Oncol; 2018 Dec; 53(6):2518-2530. PubMed ID: 30221742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer effects of 15d-prostaglandin-J2 in wild-type and doxorubicin-resistant ovarian cancer cells: novel actions on SIRT1 and HDAC.
    de Jong E; Winkel P; Poelstra K; Prakash J
    PLoS One; 2011; 6(9):e25192. PubMed ID: 21957481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15d-prostaglandin J2 protects cortical neurons against oxygen-glucose deprivation/reoxygenation injury: involvement of inhibiting autophagy through upregulation of Bcl-2.
    Qin H; Tan W; Zhang Z; Bao L; Shen H; Wang F; Xu F; Wang Z
    Cell Mol Neurobiol; 2015 Apr; 35(3):303-312. PubMed ID: 25349027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.
    Yen CC; Hsiao CD; Chen WM; Wen YS; Lin YC; Chang TW; Yao FY; Hung SC; Wang JY; Chiu JH; Wang HW; Lin CH; Chen TH; Chen PC; Liu CL; Tzeng CH; Fletcher JA
    Oncotarget; 2014 Feb; 5(3):716-25. PubMed ID: 24566468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss.
    Kim KR; Kim HJ; Lee SK; Ma GT; Park KK; Chung WY
    PLoS One; 2015; 10(4):e0122764. PubMed ID: 25859665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin 15d-PGJ
    Slanovc J; Mikulčić M; Jahn N; Wizsy NGT; Sattler W; Malle E; Hrzenjak A
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166924. PubMed ID: 37898426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons.
    Yagami T; Ueda K; Asakura K; Takasu N; Sakaeda T; Itoh N; Sakaguchi G; Kishino J; Nakazato H; Katsuyama Y; Nagasaki T; Okamura N; Hori Y; Hanasaki K; Arimura A; Fujimoto M
    Exp Cell Res; 2003 Nov; 291(1):212-27. PubMed ID: 14597421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Deoxy-Δ
    Chen K; Li JJ; Li SN; Feng J; Liu T; Wang F; Dai WQ; Xia YJ; Lu J; Zhou YQ; Guo CY
    Acta Pharmacol Sin; 2017 May; 38(5):672-687. PubMed ID: 28216619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
    Butler R; Mitchell SH; Tindall DJ; Young CY
    Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase.
    Yu X; Egner PA; Wakabayashi J; Wakabayashi N; Yamamoto M; Kensler TW
    J Biol Chem; 2006 Sep; 281(36):26245-52. PubMed ID: 16857669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-deoxy-Delta12,14-prostaglandin J2 induces renal epithelial cell death through NF-kappaB-dependent and MAPK-independent mechanism.
    Kang DS; Kwon CH; Park JY; Kim JH; Woo JS; Jung JS; Kim YK
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):426-35. PubMed ID: 16890972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-deoxy-delta 12,14-prostaglandin J2 and laminar fluid shear stress stabilize c-IAP1 in vascular endothelial cells.
    Taba Y; Miyagi M; Miwa Y; Inoue H; Takahashi-Yanaga F; Morimoto S; Sasaguri T
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H38-46. PubMed ID: 12623786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms.
    Diers AR; Higdon AN; Ricart KC; Johnson MS; Agarwal A; Kalyanaraman B; Landar A; Darley-Usmar VM
    Biochem J; 2010 Jan; 426(1):31-41. PubMed ID: 19916962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S. aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Delta12,14- prostaglandin J2 (15d-PGJ2).
    Kielian T; McMahon M; Bearden ED; Baldwin AC; Drew PD; Esen N
    J Neurochem; 2004 Sep; 90(5):1163-72. PubMed ID: 15312171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis via JNK-mediated mitochondrial pathway in osteoblastic cells.
    Lee SJ; Kim MS; Park JY; Woo JS; Kim YK
    Toxicology; 2008 Jun; 248(2-3):121-9. PubMed ID: 18450357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Deoxy-delta12,14-prostaglandin J2, a neuroprotectant or a neurotoxicant?
    Koh SH; Jung B; Song CW; Kim Y; Kim YS; Kim SH
    Toxicology; 2005 Dec; 216(2-3):232-43. PubMed ID: 16191461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
    Migita H; Morser J
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):710-6. PubMed ID: 15662020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.